PADCEV™ (enfortumab vedotin) treatment for Locally Advanced or Metastatic Urothelial Cancer receives market authorisation in Singapore
- Written by The Express
More Articles ...
- Sunlight REIT secures an additional HK$800 million Sustainability-linked Loan from BOCHK
- Comba Telecom Releases 4G/5G (8TR) Green Integrated Base Station Antenna
- AWS and HKSTP Announce Strategic Collaboration to Accelerate Innovation and Technology Development in Hong Kong
- SUNeVision Welcomes the Court of Appeal's Ruling on Potential Breaches of Lease Conditions of Data Centers in HKSTP Industrial Estates
- Drunk Robots Finds New Partners and Increases the Prize Pool in $METAL
- Meta Health Appoints Dr Bernard Ng as Chairman of the Board and Group CEO
- Insilico Medicine Raises $60 Million in Series D Financing to Advance Pipeline and Launch AI-powered Drug Discovery Robotics Laboratory
- WEAVE LIVING and PGIM REAL ESTATE Join Forces for a USD200 Million Urban Living Joint Venture
- AXA launches "AXA Climate School for university students in Hong Kong"
- Hantec Financial will attend Wiki Finance Expo 2022 in Vietnam, HCMC
- Pump Up Your Adrenaline With iShopChangi’s iShopathon
- Summer sensation on display in Denkendorf – baby allosaurus "Little Al" has arrived!
- International Cancer Specialists Provides Low-Dose CT Scans For Safer Lung Cancer Screening
- NTUC LearningHub To Innovate And Grow Under New Leadership Team
- XLD Launches xSpend in Malaysia, allows users to spend Crypto Assets for Utilities
- Apical Wins Five Awards at the Sustainable Business Awards Indonesia 2020/2021
- Sino Jet Announces Carbon Neutrality Plan
- OPPOHack 2022 – ColorOS Has Attracted Developers From More Than 50 Countries/Regions to Register Within 1 Week After Launching
- 500 Global and Taiwan Tech Arena Join Forces Again in 2022 to Fuel Early-Stage Startup Growth on a Global Scale
- Taiwan tech firms unveil a new wave of AI solutions at Computex 2022